A carregar...

Mesulergine in early Parkinson's disease: a double blind controlled trial.

The efficacy and tolerance of treatment with an 8-alpha-amino-ergoline derivative CU32-o85, Mesulergine, were compared with levodopa/benserazide (Madopar) in a 3 month double-blind controlled trial in 31 patients with Parkinson's disease, not previously treated with levodopa. The two treatments...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dupont, E, Mikkelsen, B, Jakobsen, J
Formato: Artigo
Idioma:Inglês
Publicado em: 1986
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1028763/
https://ncbi.nlm.nih.gov/pubmed/3517235
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!